Inventor · disambiguated record
Patricia Andres
Also filed as: ANDRES PATRICIA · ANDRES PATRICIA M J
47 granted patents·17 pending applications·182 citations·filing 2008–2025
98Inventor score
Top patents by PatentIndex Score
64 records- 0197US8558008B2Crystalline glycopyrrolate tosylateDERMIRA INC·Filed 2013·Granted Oct 15, 2013·22 cites·20 claims
- 0295US9259414B2Glycopyrrolate saltsDERMIRA INC·Filed 2015·Granted Feb 16, 2016·8 cites·21 claims
- 0395US9006462B2Glycopyrrolate saltsDERMIRA INC·Filed 2014·Granted Apr 14, 2015·13 cites·24 claims
- 0495US8859610B2Crystalline glycopyrrolate tosylateDERMIRA INC·Filed 2013·Granted Oct 14, 2014·15 cites·28 claims
- 0594US12139494B2Morphic forms of G1T38 and methods of manufacture thereofG1 THERAPEUTICS INC·Filed 2022·Granted Nov 12, 2024·3 cites·1 claims
- 0694US11634442B2Methods for the purification of L-glufosinateBASF SE·Filed 2018·Granted Apr 25, 2023·5 cites·4 claims
- 0794US9006461B2Crystalline glycopyrrolate tosylateDERMIRA INC·Filed 2013·Granted Apr 14, 2015·13 cites·18 claims
- 0893US11261193B2Morphic forms of G1T38 and methods of manufacture thereofG1 THERAPEUTICS INC·Filed 2019·Granted Mar 1, 2022·5 cites·20 claims
- 0992US12410184B2Crystalline forms of a menin inhibitorKURA ONCOLOGY INC·Filed 2024·Granted Sep 9, 2025·1 cites·35 claims
- 1092US8063227B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2009·Granted Nov 22, 2011·23 cites·1 claims
- 1189US10508117B2Solid forms of a toll-like receptor modulatorGILEAD SCIENCES INC·Filed 2018·Granted Dec 17, 2019·5 cites·18 claims
- 1289US8227482B1Forms of rifaximin and uses thereofPARENT STEPHAN D·Filed 2012·Granted Jul 24, 2012·13 cites·23 claims
- 1388US2024247013A1Methods for the purification of l-glufosinateBASF SE·Filed 2024·Application pending·0 cites
- 1488US2024270770A1Methods for the purification of l-glufosinateBASF SE·Filed 2024·Application pending·0 cites
- 1587US12338249B2Crystalline forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N′-methoxyureaSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2022·Granted Jun 24, 2025·1 cites·20 claims
- 1687US11976089B2Methods for the purification of L-glufosinateBASF SE·Filed 2023·Granted May 7, 2024·0 cites·2 claims
- 1787US11897909B2Methods for the purification of L-glufosinateBASF SE·Filed 2023·Granted Feb 13, 2024·0 cites·4 claims
- 1887US11897908B2Methods for the purification of L-glufosinateBASF SE·Filed 2023·Granted Feb 13, 2024·0 cites·4 claims
- 1987US10004717B2Glycopyrrolate saltsDERMIRA INC·Filed 2017·Granted Jun 26, 2018·5 cites·31 claims
- 2086US9610278B2Glycopyrrolate saltsDERMIRA INC·Filed 2016·Granted Apr 4, 2017·4 cites·33 claims
- 2185US12152037B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitorKRONOS BIO INC·Filed 2022·Granted Nov 26, 2024·1 cites·7 claims
- 2285US9133217B2Forms of rifaximin and uses thereofPARENT STEPHAN D·Filed 2014·Granted Sep 15, 2015·6 cites·16 claims
- 2384US10604467B2Solid forms of cannabidiol and uses thereofARTELO BIOSCIENCES INC·Filed 2019·Granted Mar 31, 2020·2 cites·9 claims
- 2484US9120766B2Methods of making cocrystalsAPTUIT WEST LAFAYETTE LLC·Filed 2012·Granted Sep 1, 2015·7 cites·15 claims
- 2584US8735419B2Forms of rifaximin and uses thereofPARENT STEPHAN D·Filed 2012·Granted May 27, 2014·6 cites·12 claims
- 2684US8507517B2Forms of rifaximin and uses thereofPARENT STEPHAN D·Filed 2012·Granted Aug 13, 2013·6 cites·12 claims
- 2784US8410127B2Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine saltsSONG JIANGAO·Filed 2010·Granted Apr 2, 2013·9 cites·12 claims
- 2879US12281113B2Crystalline forms of a KRas G12C inhibitorMIRATI THERAPEUTICS INC·Filed 2024·Granted Apr 22, 2025·0 cites·30 claims
- 2979US11339168B2Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitorsKRONOS BIO INC·Filed 2020·Granted May 24, 2022·1 cites·4 claims
- 3078US10548875B2Glycopyrrolate saltsDERMIRA INC·Filed 2018·Granted Feb 4, 2020·1 cites·27 claims
- 3177US10543192B2Glycopyrrolate saltsDERMIRA INC·Filed 2018·Granted Jan 28, 2020·1 cites·41 claims
- 3277US2025304592A1Morphic forms of g1t38 and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2024·Application pending·0 cites
- 3376US11773098B2Solid forms of a toll-like receptor modulatorGILEAD SCIENCES INC·Filed 2021·Granted Oct 3, 2023·0 cites·20 claims
- 3476US2025186395A1Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2025·Application pending·0 cites
- 3574US9682988B2Solid salt form of α-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereofNEKTAR THERAPEUTICS·Filed 2013·Granted Jun 20, 2017·3 cites·5 claims
- 3674US2025313566A1CRYSTALLINE FORMS OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[l,2-a]PYRAZIN-8-AMINE AS SYK INHIBITORSKRONOS BIO INC·Filed 2024·Application pending·0 cites
- 3773US2025282778A1Crystalline forms of a kras g12c inhibitorMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3872US11291652B2Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2020·Granted Apr 5, 2022·0 cites·17 claims
- 3972US11291651B2Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2020·Granted Apr 5, 2022·0 cites·23 claims
- 4072US8846731B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2011·Granted Sep 30, 2014·1 cites·7 claims
- 4172US2025361242A1Crystalline forms of a menin inhibitorKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 4271US8829197B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2011·Granted Sep 9, 2014·1 cites·3 claims
- 4371US8710087B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2011·Granted Apr 29, 2014·1 cites·6 claims
- 4470US12466835B1Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the sameKURA ONCOLOGY INC·Filed 2024·Granted Nov 11, 2025·0 cites·28 claims
- 4570US2023404939A1Solid forms of cannabidiol and uses thereofARTELO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4669US12286431B2Crystalline forms of a KRas G12C inhibitorMIRATI THERAPEUTICS INC·Filed 2021·Granted Apr 29, 2025·0 cites·19 claims
- 4767US2019177258A1New solid forms of cannabidiol and uses thereofARTELO BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 4865US11787819B2Crystalline salt of a multi-tyrosine kinase inhibitor, method of preparation, and use thereofMIRATI THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·0 cites·28 claims
- 4965US9512166B2Cocrystals of progesteroneAMRI SSCI LLC·Filed 2013·Granted Dec 6, 2016·0 cites·9 claims
- 5064US11364202B2Solid forms of cannabidiol and uses thereofARTELO BIOSCIENCES INC·Filed 2020·Granted Jun 21, 2022·0 cites·14 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Patricia Andres files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →